Group 1: Stock Trading Anomaly - The stock of Dezheng Health has experienced an abnormal trading fluctuation, with a cumulative closing price increase of 23.06% over two consecutive trading days (July 30 and July 31, 2025) [2] - The company's board has conducted an investigation and confirmed that there are no undisclosed significant matters affecting the stock price [3][4] Group 2: Share Repurchase and Cancellation - The company has completed the cancellation of 67,850,450 shares, which accounts for 3.13% of the total share capital prior to cancellation [8][12] - The repurchased shares were acquired through a plan approved at the 2024 first extraordinary general meeting, with a total repurchase amount of 200,884,766.50 yuan [9][10] - Following the cancellation, the total share capital has decreased from 2,164,955,990 shares to 2,097,105,540 shares [12][13] Group 3: Impact of Share Cancellation - The cancellation of shares is expected to enhance earnings per share and improve returns for shareholders without adversely affecting the company's financial, operational, or debt obligations [13] - The share cancellation will not lead to changes in company control or affect its listing status [13]
德展大健康股份有限公司 股票交易异常波动公告